Sompharmaceuticals
Epalinges
About Sompharmaceuticals
Sompharmaceuticals is a Swiss biopharmaceutical company based at the Biopôle in Epalinges-Lausanne, Switzerland. Their focus is on developing novel anti-tumour somatostatin analogue (SSA) peptide medicines and diagnostics for patients with rare diseases, which have unmet medical needs and major market opportunities, including growth hormone producing pituitary brain tumours (acromegaly) and malignant neuroendocrine hormone producing intestinal and pancreatic tumours (NETs) that are resistant or poorly controlled with currently available SSA treatments, octreotide and lanreotide.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $959.1K
- Funding stage: M&A
- Last round: Series A (Apr 2014)
- Website: sompharmaceuticals.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Clinical Trials, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/sompharmaceuticals-3730814 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.